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ABSTRACT
Prediabetes is a condition in which a person has impaired glucose metabolism;
however, his or her glucose levels do not meet criteria for the diagnosis of diabetes
(ADA, 2019). Prediabetes is associated with an increased risk of developing diabetes
and cardiovascular disease (ADA, 2019). Early diagnosis and treatment of prediabetes,
including lifestyle interventions and medical management, are vital in preventing
prediabetes from progressing to diabetes. The review of current literature indicates that
prediabetes testing is not being properly utilized in primary care settings. The purpose of
this study was to determine if primary care providers (PCPs) were performing
prediabetes A1C screenings for patients 18 and older who were overweight, obese, or
had a BMI that was 25 or greater, as well as one or more additional risk factors for
prediabetes; the study also included patients who were 45 or greater without further risk
factors. The intention was to bring awareness of the proper guidelines required of PCPs
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in testing patients for prediabetes. It is the obligation of PCPs to test asymptomatic
patients who are at risk of developing prediabetes or diabetes mellitus (ADA, 2019).
Primary care providers can use this information to increase their knowledge and practice
of performing appropriate testing on overweight and obese patients.
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Chapter I
Prediabetes and Dimensions of the Problem in Mississippi
The Centers for Disease Control and Prevention (CDC) estimate that 12.2% (30.3
million) of American adults have diabetes, and that 7.2 million of those people are
undiagnosed (CDC, 2015). Perhaps even more startling than those figures is that the
CDC reports that 33.9% (84.1 million) of adults (≥18) in the United States are
prediabetic, according to their fasting plasma glucose or A1C (CDC, 2017). Prediabetes
is a condition in which a person has impaired glucose metabolism; however, his or her
glucose levels do not meet criteria for the diagnosis of diabetes (ADA, 2019).
Prediabetes is defined by the American Diabetes Association (ADA) as having an A1C
5.7-6.4% or fasting plasma glucose of 100-125 mg/dl. The condition is associated with
an increased risk of developing diabetes and cardiovascular disease (ADA, 2019).
Early diagnosis and treatment of prediabetes with lifestyle interventions and
medical management are vital to prevent prediabetes from progressing to diabetes.
Therefore, it is the obligation of primary care providers (PCPs) to test asymptomatic
patients who are at risk of developing prediabetes or diabetes mellitus (ADA, 2019). The
ADA is considered the authority on diabetes; therefore, they publish Standards of
Medical Care in Diabetes to guide the care of patients with diabetes and those who may
be at risk of developing diabetes. The ADA’s guidelines state that testing should include
the following populations: overweight and obese adults with one or more risk factors for
diabetes, as well as adults 45 and older, regardless of BMI and risk factors. If prediabetes
is not diagnosed in these populations, testing should be repeated every 3 years. It is
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recommended that individuals who are diagnosed with prediabetes be screened annually,
and women with a history of gestational diabetes be screened every 3 years for life
(ADA, 2019). The testing should be conducted using one of three methods: the fasting
plasma glucose (FPG), the 2-hour plasma glucose (2-h PG) value during 75g oral glucose
tolerance test (OGTT), or A1C criteria (ADA, 2019). The goal of testing asymptomatic
people with risk factors is to detect prediabetes early and prevent complications.
Considering the rate of prediabetes is prevalent in America, despite only 11.6% of
the population with knowledge of their condition, many people will develop diabetes and
never have the opportunity to slow down the progression or stop it altogether (CDC,
2017). There is sufficient evidence that microvascular complications occur in
prediabetes; therefore, treatment is appropriate and necessary for this population of
patients (Perreault et al., 2019). The ADA recommends intensive lifestyle intervention
with diet, exercise, and weight loss and medical management with Metformin for
prediabetic patients (ADA, 2019). Although the goal of treatment of prediabetes is
regression to normoglycemia, it is important to consider the sequelae of untreated or
undiagnosed diabetes in order to fully comprehend the magnitude of undiagnosed
prediabetes. Prediabetes and diabetes are associated with increased risk of peripheral
neuropathy, retinopathy, nephropathy, cardiovascular disease, peripheral artery disease
(PAD), stroke, and infection (Brashers, Jones, & Huether, 2019). According to the CDC
diabetic patients greater than 35 years old have the following rates of CVD: 17.8%
coronary heart disease, 16% heart disease or stroke, and 31% other heart
disease (CDC, 2015). The CDC also reported that 20% of diabetics have visual
impairment and 77.6% of diabetics have one of the following lower extremity conditions:
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PAD, ulcers, or neuropathy (CDC, 2015). While these numbers represent a more
advanced stage of hyperglycemia, it is indicative of complications that may occur if
prediabetes is not diagnosed and treated.
In Mississippi, diabetes affects 13.6% of the population (308,295), meaning the
state has the highest rate of diabetes in the country (CDC, 2015). When prediabetes is
not treated and progresses to diabetes, there are not only health consequences but there
are also financial and economic implications as well. The financial burden of diagnosed
diabetes in the United States for 2017 was “$327 billion, including $237 billion in direct
medical costs and $90 billion in reduced productivity” (ADA, 2018). In 2012, the
estimated cost of diabetes in Mississippi was $2.74 billion; this figure rounds out to
costing Mississippians with diabetes approximately $10,402 for proper care and
management (MSDH, 2013). When the potential complications of uncontrolled diabetes
are considered, it explains why “people with diagnosed diabetes, on average, have
medical expenditures ~2.3 times higher than what expenditures would be in the absence
of diabetes” (ADA, 2018). Early detection of prediabetes is of utmost importance
particularly when considering the health consequences and financial burden of diabetes.
Problem Statement
According to the National Health and Nutrition Examination Survey (NHANES),
the rate of undiagnosed total diabetes is highest in people ages 20-44, and lowest in
people ages 65-74 (Cowie, 2019). Mississippi has the highest rate of diabetes in the
country which affects 13.6% (308,295) of the population (CDC, 2015). Primary care
providers have the responsibility to test, diagnose, and treat patients for prediabetes. A
possible explanation for the high rate of undiagnosed prediabetes in the adult population
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is that PCPs are not screening according to the ADA’s guidelines for prediabetes in
asymptomatic adult patients (ADA, 2019). The complications of untreated diabetes
begin early in the disease process and patients may be asymptomatic until significant
damage has already occurred (Cowie, 2019). Overtime, high blood glucose from
diabetes can damage blood vessels and the nerves that control the heart and blood
vessels; therefore, the longer a person has diabetes, the higher their chances are for
developing heart disease (NIH, 2017). According to the National Institute of Diabetes
and Digestive and Kidney Disease, adults with diabetes are twice as likely to die from
heart disease or stroke (NIH, 2017). The consequences of undiagnosed and/or untreated
diabetes affects not only the quality of life of patients, it also has a major economic
impact on society (ADA, 2018).
Statement of Purpose
The purpose of this study was to determine if primary care providers in
Mississippi were performing prediabetes A1C testing for high-risk patients. This
includes patients who are18 and older who are overweight, obese, or have a BMI that is
25 or greater and have one or more additional risk factors for prediabetes. In addition,
patients who are 45 or older without further risk factors should be tested regularly.
Overweight and obese individuals have increased body fat causing increased insulin
resistance, which in turn increases the risk of prediabetes. In addition to exploring the
frequency of testing, the researchers assessed the treatment plans for prediabetic patients,
as recommended by the ADA. ADA recommendations include lifestyle modifications
(diet, exercise, and weight loss) and medication management (Metformin) (ADA, 2019).
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Significance of the Study
The significance of this study was to determine if Mississippi primary care
providers are utilizing the recommendations set forth by the ADA in order to raise
awareness of prediabetes in adult patients. Overall, the importance of this study is to
educate PCPs and attempt to prevent lasting detrimental effects caused from undiagnosed
diabetes. Among these are peripheral neuropathy, diabetic retinopathy, diabetic
nephropathy, cardiovascular disease, peripheral artery disease, stroke, and infection.
Theoretical Framework
This research project was be guided by Nola Pender’s Health Promotion Model
(HPM). This model is appropriate for guiding this study because it focuses on health
promotion and the overall well-being of people. The HPM provides a holistic approach
to nursing care. Pender defines the goal of nursing care as “the optimal health of the
individual” (Sakraida, 2018, p. 323). Through Pender’s experiences in education, human
development, nursing, and psychology, she formed the foundation for the HPM. The
HPM recognizes not only individuals, but also the environment that surrounds them in
regards to overall health. This model is highly focused on self-efficacy and the needed
behaviors to enhance one’s health throughout his or her life. The HPM looks at
individual characteristics and experiences, behavior-specific cognitions and affects, and
behavioral outcomes as a basis for promoting one’s overall health. The HPM is easy to
understand, and its utilization allows both patients and primary care providers to become
more knowledgeable and empowered in health-promoting abilities. Based on the HPM,
individuals are more likely to follow recommendations or guidelines if they can foresee
the potential benefits of compliance, versus the possible consequences of non-
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compliance. The HPM incorporates multiple theoretical assertions that include
behaviors, commitment, barriers, competence, self-efficacy, influences, and the
interpersonal and physical environment. With the prevalence of preventable diseases at
an all-time high, health promotion should be at the forefront of primary care treatment.
Application of the HPM has boundless potential to prevent disease and improve clinical
outcomes in this setting. Further, primary care providers have the opportunity to educate,
empower, and promote the health of their patients by utilization of the HPM (Sakraida,
2018).
Research Questions
1. Are primary care providers testing for prediabetes using the A1C of
overweight or obese patients ages18 years old or older and have one or more
of the following additional risk factors for prediabetes, history of CVD
(angina, MI, or coronary stents) or a diagnosis of Essential Hypertension?
2. Are primary care providers testing for prediabetes using the A1C of patients
45 years old or older, regardless of risk factors?
3. For prediabetic patients with A1C results between the ranges 5.7% -6.4%, are
PCPs prescribing Metformin and/or lifestyle interventions?
Definitions of Terms
Primary care provider
Theoretical: Taber’s (2013) defines a primary care provider as “the health care
provider (nurse practitioner, physician’s assistant, or physician) to whom a patient first
goes to address a problem with his or her health.”
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Operational: For the purpose of this study, the term primary care provider is
defined as a nurse practitioner, medical doctor, or doctor of osteopathy providing care in
one of the five clinics selected.
A1C Testing
Theoretical: Taber’s (2013) defines Hb A1C as “hemoglobin A contains a
glucose group linked to the terminal amino acid of the beta chains of the molecule.”
Operational: For the purpose of this study, the term A1C is defined as a test for
determining if a patient has prediabetes or diabetes mellitus that is documented in the
medical record between January 1, 2017 and December 31, 2019.
Prediabetes
Theoretical: Taber’s (2013) defines prediabetes as “early evidence either of
autoimmune disease or impaired carbohydrate metabolism in patients who later develop
overt diabetes mellitus.”
Operational: For the purpose of this study, the term prediabetes is defined as
patients having an A1C between 5.7-6.4% that is recorded in the medical record between
January 1, 2017 and December 31, 2019 (ADA, 2019).
Overweight
Theoretical: Taber’s (2013) defines overweight as “having weight in excess of
what is normal for a person’s age, height, and build. Having a BMI that exceeds the 95th
percentile of other people of the same age. Having a body mass index greater than 25.”
Operational: For the purpose of this study, the term overweight is defined as
having a BMI between 25-29.9% that is recorded in the medical record.
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Obese
Theoretical: Taber’s (2013) defines obese as “having a body mass index in excess
of 30.”
Operational: For the purpose of this study, the term obese is defined as having a
BMI of 30 or above that is recorded in the medical record.
Cardiovascular disease (CVD)
Theoretical: Taber’s (2013) defines cardiovascular disease as “any disease of the
heart or blood vessels, including atherosclerosis, cardiomyopathy, coronary artery
disease, peripheral vascular disease, and others.”
Operational: For the purpose of this study, cardiovascular disease will be defined
as any history recorded in the medical record of coronary stents, myocardial infarction, or
angina, or any of the above.
Hypertension
Theoretical: Taber’s (2013) defines hypertension as, “in adults, a condition in
which the blood pressure is higher than 140 mm Hg systolic or 90 mm Hg diastolic on
three separate readings recorded several weeks apart.”
Operational: For the purpose of this study, hypertension is defined as a diagnosis
of essential hypertension, ICD-10 code I10 recorded in the electronic medical record.
Metformin
Theoretical: Taber’s (2013) defines Metformin as “an oral antidiabetic agent used
to treat elevated blood sugar levels in patients with type 2 diabetes mellitus.”
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Operational: For the purpose of this study, Metformin will be defined as
treatment recorded in the medical record for patients with an A1C of 5.7-6.4% between
January 1, 2017 and December 31, 2019 (ADA, 2019).
Lifestyle Modification
Theoretical: Taber’s (2013) defines lifestyle modification as “the act or result of
changing a person’s pattern of living and behavior, especially as distinguished from the
behavior patterns or life choices of others.”
Operational: For the purpose of this study, lifestyle modification is defined as any
documentation of diet, exercise, or weight loss counseling in the electronic medical
record.
Body Mass Index (BMI)
Theoretical: Taber’s (2013) defines Body Mass Index as “an index for estimating
obesity. A BMI can be obtained by dividing weight in kilograms by height in meters
squared. A BMI ≥ 30 indicates obesity. A BMI greater than 40 indicates morbid
obesity. A BMI <18.9 indicates underweight. A BMI of 25-29.9 is considered to be
overweight.”
Operational: For the purpose of this study, the term BMI is defined as a value
used to identify overweight and obese patients and results are recorded in the medical
record. Normal BMI 19-24.9, overweight BMI 25-29.9, obesity BMI ≥ 30.
Assumptions
Assumptions in this study included the following:
1. PCP were adherent to the ADA guidelines for assessing overweight and obese
patients for prediabetes.
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2. Data needed to conduct this research was easily accessible through chart
reviews and consistent among all clinics included in the project.
3. Data collection was correctly interpreted by the researchers.
4. Researchers adhered to all information on the data collection worksheet while
collecting data.
5. Frequency of ADA guideline adherence was measurable by the chart review
method completed.
6. Data collected was gathered and stored in a legal, confidential manner and
kept in an encrypted file.
Limitations
Limitations in this study included the following:
1. Small sample size of 500 charts reviewed in 5 Mississippi clinics.
2. Limited access to corporately-owned clinics due to Institutional Review
Boards.
3. Limited time frame for research project completion.
4. Limited review of lab values to include only A1C results.
Summary
The primary goal of this study was to evaluate Mississippi primary care
providers’ (PCPs) screening practices for prediabetes in patients 18 years or older who
are overweight or obese with one or more risk factors, as well as those ages 45 or greater,
with or without risk factors. When prediabetes is discovered early, the development and
progression of complications can be slowed or eliminated completely by utilization of
recommended lifestyle modifications and medical treatment. According to the CDC,

11
there are 84.1 million American adults with prediabetes, and the rate of undiagnosed
diabetes is highest in younger age groups, aged 20 to 44, which may be directly related to
PCPs not abiding by the recommendations of the ADA (CDC, 2017; Cowie, 2019). Once
the research project was completed, the researchers were able to determine whether
overweight or obese adults were being tested for prediabetes in order to prevent
complications of undiagnosed and untreated prediabetes. With the results of this study,
the researchers plan to disseminate the findings to PCPs in Mississippi in an effort to
increase testing practices and early treatment of prediabetes.

CHAPTER II
Literature Review
The purpose of this study was to determine if Mississippi primary care providers
were utilizing the ADA testing guidelines for prediabetes in overweight and obese
individuals. It is acknowledged that overweight and obese individuals have an increased
risk of developing prediabetes. Detection and treatment of prediabetes is imperative for
diabetes prevention, and the following review of current literature indicates that
prediabetes testing is not being properly utilized in all primary care settings. The
intention was to provide primary care providers with the awareness of the proper
guidelines for testing overweight and obese patients for prediabetes. Once an at-risk
patient has been identified, it is imperative that proper testing following ADA guidelines
takes place to prevent both progression to type 2 diabetes mellitus and complications of
prolonged elevated glycemic exposure. This chapter will provide previously explored
data on prediabetes screening in overweight and obese patients. The literature reviews
illustrate the benefits of prediabetes testing in overweight and obese individuals and
benefits of early intervention.
Testing Practices and Adherence to Guidelines
Mehta, Mocarski, Wisniewski, Gillespie, Venkat Narayan, and Lang (2017)
studied primary care physicians’ knowledge of and adherence to current screening
guidelines from the American Diabetes Association (ADA) and United States Preventive
Services Task Force (USPSTF) for type 2 diabetes. The team studied the relationship
between self-reported adherence to screening guidelines and actual practice application of
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the guidelines, as well as referral practices to diabetes prevention and self-management
education programs (DPP/DSME). According to the Centers for Disease Control and
Prevention (CDC), in 2012, diabetes affected 29.1 million people, with 28% previously
undiagnosed. The rate of prediabetes in Americans aged ≥20 years is 86 million with
90% unaware of it. Early detection of diabetes is critical; however, the rate of screening
per the ADA/USPSTF’s guidelines have been shown to be suboptimal (46%-85%). This
study sought to further understand primary care physicians’ screening practices and
management of newly diagnosed patients with prediabetes and diabetes. Although no
hypothesis was stated by the researchers, the objectives of the study were clearly stated.
No stated theoretical framework was utilized in this study.
Mehta et al. (2017) utilized online surveys for physicians and electronic medical
record reviews (EMR) to conduct this study. Strict patient and physician inclusion and
exclusion criteria were utilized. The physician’s National Provider Identifier (NPI)
number was used to link the survey with the patients for comparison of survey and
practice. Eligible patients were followed for 3 years to determine if the screening
guidelines were followed. Types of screening tests included fasting or random plasma
glucose, oral glucose tolerance test, and hemoglobin A1C.
The physician surveys included questions regarding demographics and practice
settings, preferred screening test, factors considered when determining whether to screen
patients, preferred guidelines, attitude toward ADA/USPSTF screening guidelines, and
recommendations for lifestyle modifications or referrals to DPP/DSME program.
Equations were utilized to determine the alignment between physician survey responses
and clinical evidence from EMR. Mehta et al. (2017) utilized multivariable logistic
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regression models to determine whether physician and practice characteristics influenced
adherence to screening guidelines.
In the study conducted by Mehta et al. (2017), 305 physician surveys were
completed, with 281 of these physician surveys linked to EMR data of 123,990 patients.
The results indicate that 76% of physicians considered screening guidelines important,
but that 78% of physicians also rely on clinical experience in determining when to screen
patients. Of the physicians surveyed, 71% reported use of ADA’s guidelines, 64%
reported use of USPSTF’s guidelines, and 38% reported use of both ADA and USPSTF
guidelines. The results of the physician surveys indicate that, while guidelines are
reportedly relied upon in practice, only 26% of the physicians use them 100% of the time
and 53% use them more than 70% of the time. When assessing concordance of
physicians self-reported utilization of screening guidelines with actual practice, one-third
of physicians who reported using the guidelines did not use them in clinical practice.
Findings in this study indicate that physicians may not be aware of guidelines, but instead
are relying on similar fundamental concepts in screening for diabetes. Screening for
prediabetes and diabetes was completed 71% of the time for patients eligible within the 3
years reviewed by researchers in this study. Physicians indicated that hemoglobin A1C
(60%) was their preferred screening method for prediabetes and diabetes. According to
physician survey responses, approximately 95% of patients diagnosed with diabetes or
prediabetes were provided education on lifestyle and diet alterations. Regarding
physicians’ referral to DPP/DSME, 45% of patients diagnosed with prediabetes and 67%
of patients diagnosed with diabetes were referred to these programs.
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In the study conducted by Mehta et al. (2017), the characteristics of the physicians
surveyed are similar to characteristics of physicians in the United States in general.
Therefore, the survey responses can be generalized to physicians across the country. The
patient population included a large cohort of patients (123,990), who were followed for 3
years by the surveyed physician. Both the generalizability of the physician sample and
the large cohort of patients are strengths in this study; however, there were several
limitations noted, as well. This study included surveys which are subject to nonresponsebias and recall bias, and it utilized retrospective EMR reviews, which are subject to
missing or incorrect data and gaps in the medical record. Also, free text data included in
the EMR was not accessible to researchers which could limit information necessary for
this study. Nurse Practitioners (NPs) and Physician Assistants (PAs) were not included
in the PCP population; however, NPs and PAs provide care for a large portion of patients
in the United States. Mehta et al. (2017) indicated that areas for future research would
include identifying barriers to consistent screening and DPP/DSME enrollment and
identifying changes in policy by Medicare and other insurance plans regarding
reimbursement of HbA1C for screening.
Tseng, Greer, O’Rourke, Yeh, McGuire, Clark, and Maruthur (2017) performed a
descriptive analysis with the purpose of assessing primary care providers’ (PCPs)
knowledge of recommended screening for diagnosing prediabetes, management of
prediabetes, and PCPs’ attitudes and beliefs about prediabetes in general. An estimated
70% of prediabetic individuals eventually develop diabetes (Tseng et al., 2017). The
ADA is one organization that has established guidelines for screening and management
of prediabetes. This study utilized those guidelines to identify any gaps in care provided
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by PCPs preventing early diagnosis. According to the ADA, prediabetes is diagnosed
with one of the following laboratory tests: fasting glucose of 100-125mg/dl, hemoglobin
A1C of 5.7-6.4%, or 2-h post-stimulation glucose of 140-199 mg/dl. Prediabetes is
associated with increased mortality, increased risk of autonomic neuropathy, and
idiopathic polyneuropathy. Studies have shown that lifestyle interventions are effective
in preventing diabetes. There was no theoretical framework identified in this article.
The research objectives being analyzed in this study included the following:
PCPs’ knowledge of risk factors that should prompt prediabetes screening, laboratory
criteria for diagnosing prediabetes and guidelines for management of prediabetes,
management practices surrounding prediabetes, and attitudes and beliefs about
prediabetes. The results of this study were intended to increase PCPs’ awareness and
knowledge of ADA guidelines concerning prediabetes, illustrate the importance of
screening for prediabetes, and exhibiting proper management of prediabetes (Tseng et al.,
2017).
This study was conducted at an annual provider retreat in 2015 that consisted of
156 adult PCPs from 40 multispecialty clinics across the mid-Atlantic region. A
convenience sampling method was utilized for this nonexperimental descriptive research
study. All 156 of the PCPs in attendance were invited to participate in the survey; 140 of
which agreed to participate, yielding 96% participation. All of the participants were
given a $10 gift card. PCPs participating included physicians, nurse practitioners, and
physicians’ assistants. The survey included multiple questions, addressing the following:
knowledge of risk factors that should prompt prediabetes screening, laboratory criteria for
diagnosing prediabetes, guidelines on recommended therapy for prediabetes,
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management practices for prediabetes, attitudes and beliefs regarding prediabetes, and its
management concerning lifestyle modification and the use of Metformin (Tseng et al.,
2017). There were multiple variables of interest included in this study; however, none
were distinguished as dependent or independent variables. This study was exempted by
the John Hopkins University School of Medicine Institutional Review Board (Tseng et
al., 2017). Survey data was entered into Microsoft Access (2013) to quantify the data
obtained. For questions that used a Likert scale, the researchers dichotomized the
answers.
Following statistical analysis, key statistics about the participants were identified
including the following: 93% physicians, 72% female, 55% white, 23% Asian, 14%
African American, and 59% practicing at least 10 years. Key results pertaining to the
objectives included that only 6% of PCPs identified all the risk factors for prediabetes,
with 17% identifying correct laboratory parameters of fasting glucose and hemoglobin
A1C for diagnosing prediabetes. Nearly 90% reported follow-up within 6 months for
patients with prediabetes. Less than 11% referred patients to a behavioral weight loss
program as initial management of prediabetes. In addition, 99% reported counseling
patients on the value of diet and physical activity as initial management; however, only
45% chose 150 minutes or more of recommended physical activity. Ninety-six percent
agreed on the importance of diagnosing prediabetes and 86% agreed that patients with
prediabetes progress quicker than those with normoglycemia. Of those surveyed, 96%
reported that lifestyle modifications reduce that progression and 78% agreed that the use
of Metformin reduces the progression also. During a post-hoc analysis, those who were
neutral or disagreed with Metformin’s ability to reduce the progression from prediabetes
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to diabetes were less likely to prescribe Metformin. Multiple barriers to lifestyle
modification and the use of Metformin were identified. Interventions for improvement in
practice were also identified. Critical gaps were identified concerning PCPs’ knowledge
and current practice standards to include the lack of using evidence-based practice
guidelines. Areas for future research include addressing knowledge gaps related to
prediabetes screening and diagnosis, as well as the lack of behavioral weight loss
program utilization in prediabetics (Tseng et al., 2017).
Tseng et al., (2017), reported the following strengths in this study: high response
rate (90%), use of a comprehensive and detailed survey, and access to the first reported
data on PCPs’ knowledge related to prediabetes. The researchers identified limitations to
include that the sample may not be generalizable, may recall bias, and may cause social
desirability bias. This study is highly relevant to the current research project, as both are
concerned with bringing awareness to the ADA guidelines and the importance of early
diagnosis. This research study recommends future research to address knowledge gaps
related to prediabetes screening and diagnosis. Thus, this study explores these two
important facets in combating prediabetes.
Mainous, Tanner, Scuderi, Porter, and Carek used a cohort study analyzing a
survey to evaluate practicing primary care physicians’ attitudes toward prediabetes
screening and perceived barriers to diabetes prevention. The investigators submitted
questions related to diabetes prevention in the survey. The survey was limited to only
United States members of Council of Educational Research Alliance (CERA) affiliated
organizations for participation. This study was approved by the American Academy of
Family Physicians Institutional Review Board. There was no theoretical framework
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identified in this study. The researchers noted that, to their knowledge, this was the first
study to focus on attitudes towards prediabetes and how those attitudes affect diabetes
prevention among practicing family physicians in the United States of America (Mainous
III, Tanner, Scuderi, Porter, & Carek, 2016, p. 670).
The researchers analyzed a survey completed by 1,248 practicing physicians over
a two-month time span in 2016. The survey addressed questions related to diabetes
prevention, demographics, current diabetes prevention practices, physicians’ attitudes
toward diabetes prevention, and perceived barriers to diabetes prevention. The genders
included in this study were 50.4% male and 40.6% female (p=<.0001). Ethnicities
included were 4.4% Hispanic, 81.8% were non-Hispanic white, 4.4% were non-Hispanic
black, and 9.4% were Asian/other (p=.003). The age range of the practicing physicians
were 20-60+ years and the physician’s years in practice ranged from 1-30+
years. The physicians included in the survey were 90.7% MDs, 8.9% DOs, and 0.4%
other (Mainous III et al., 2016).
Results of the study concluded that female physicians, younger physicians,
minority physicians, and physicians who have been practicing fewer years have a more
positive attitude toward the idea of using prediabetes as a diagnostic concept. The survey
results showed that 58% of the sampled physicians focused on dietary modifications,
weight loss, and increasing leisure time physical activity. The survey concluded that
52.1% of physicians used blood glucose concentrations for their primary mode of testing.
A total of 52.4% of the surveyed physicians were following the national guideline or
screening recommendation (p=<.0001). The primary method of identifying someone at
risk of developing diabetes used in this study was assessing BMI, testing blood glucose
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concentrations, inquiring about family history, and other (p=.11). Overall, the study
showed that physicians with a positive attitude toward the idea of using prediabetes as a
diagnostic concept were more likely to use the American Diabetes Association as their
primary guideline for prediabetes screening. The data collected showed that 35.5% of
physicians used the current USPSTF guidelines and 25.2% of physicians used the
American Diabetes Association guidelines for screening (p=.0001) (Mainous III et al.,
2016).
Numerous perceived barriers were identified from the survey. Of the surveyed
physicians, 83.2% chose sustaining patient motivation as an extreme barrier to diabetes
prevention. Other barriers included: patients’ medication compliance, insurance
coverage of education for patients, time needed to educate patients on diet and lifestyle
change, economic resources of patients, and time for patient follow-ups (Mainous III et
al., 2016).
The weakness identified in the study was that new guidelines from the ADA and
USPSTF were released four months before the survey was sent out to participating
physicians. Therefore, the researchers noted they could not be sure if the physicians who
responded were following recently released guidelines within four months of this study,
or if the physicians were following the guidelines that were current four months prior
(Mainous III et al., 2016).
This article relates directly to our research on assessment of diabetes screening
practices of primary care providers in Mississippi. The overall results of this article
clearly show that further education on following current guidelines, embracing positive
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attitudes toward prediabetes screening, and educating patients are all crucial in diabetes
prevention.
Undiagnosed Prediabetes
Selvin, Wang, Lee, Bergenstal, & Cornesh (2017) proposed that prior
epidemiologic studies overestimated the amount of undiagnosed diabetes. Left untreated,
T2DM can result in renal disease or failure, retinopathy, cardiovascular and peripheral
vascular disease, gastroparesis, wound complications, etc. (Hollier, 2018, p. 223). The
prior epidemiologic studies had shown that one-quarter to one-third of diabetics are
undiagnosed, so the authors conducted a cross-sectional study of U.S. adults 20 years of
age or older. Selvin et al. (2017) wanted to provide national estimates of undiagnosed
diabetes by using confirmatory tests. In their study, they used the Hemoglobin A1C
(HbA1C) and plasma glucose concentrations as confirmatory tests. They used the
American Diabetes Association (ADA) guidelines for unclear diagnoses; in other words,
a second test should be required to diagnose diabetes. No theoretical framework was
identified in this study.
Selvin et al. (2017) proposed the question of whether undiagnosed diabetes
estimates from 1988-1994 were overestimated based on the ADA guidelines. The
authors conducted a cross-sectional study using survey results from 1988-1994 and 19992014. These surveys were from National Health and Nutrition Examination. The authors
included non-pregnant U.S. adults 20 years of age and older. They used data from
NHANES III- and 4-year survey cycles. They excluded persons with missing fasting
glucose or HbA1C, as well as those who self-reported insulin use, but did not report a
diabetes diagnosis. The authors wanted to ensure to abide by the ADA guidelines.
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Selvin et al. (2017) admitted there were several limitations to their study. First,
they admitted they limited their study to the fasting glucose and HbA1C levels in a single
blood sample, rather than a second blood sample for confirmation. Secondly, they had
surveys which allowed self-reporting of persons diagnosed with diabetes, which may
have caused miscalculation. Thirdly, they used only fasting blood glucose measurements
in morning samples of NHANES surveys, which is considered less precise. Lastly,
NHANES surveyed only non-institutionalized adults, which likely left out a segment of
the population.
Selvin et al. (2017) were able to defend their hypothesis of overestimation. They
were able to determine a significant decrease from 1988-1994 (16.3%) and 2011-2014
(10.9%). The study showed that the U.S. is doing a better job of screening and
diagnosing than was inferred. The authors were also able to determine age and body
mass index (BMI) as the major risk factors for diabetes. They pointed out that all
patients 45 years of age and older should be screened for T2DM, and that men are more
likely to be undiagnosed. Insurance coverage, lack of access to health care, and missed
screening practices were discovered to be factors indicating why these undiagnosed
diabetics remain undiagnosed (which could create the framework for possible guideline
changes in the future).
This study implies that if we, as primary care providers, can decrease the lack of
medical care access, increase insurance coverage of screening, and decrease the amount
of missed screening practices of those who are high risk the amount of undiagnosed
diabetes could be greatly decreased. If primary care providers can decrease undiagnosed
diabetes, then the burden created by the complications of T2DM can also be decreased.
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Complications of untreated prediabetes and diabetes
Perreault, Pan, Schroeder, Kalyani, Bray, Dagogo-Jack, White, Goldberg, Kahn,
Knowler, Mathioudakis, and Dabelea, (2019) as part of the Diabetes Prevention Program
Outcomes Study (DPPOS), examined the effects of the Diabetes Prevention Program
(DPP) on participants and whether the transition from prediabetes to normoglycemia
affected the development of microvascular disease in participants. The DPP was a
randomized control clinical trial that utilized intensive lifestyle intervention, Metformin,
and placebo to determine the possibility of preventing or delaying the progression of
prediabetes to diabetes. There is sufficient evidence to support that microvascular
complications occur in prediabetes; and therefore, treatment is appropriate and necessary
for this population of patients. Past research has sought to determine the exact threshold
at which diabetic complications occur; however, it has proven to be a difficult task and “it
may be time to revisit whether prediabetes is actually an earlier form of diabetes”
(Perreault et al., 2019, p. 1814).
The hypothesis and research questions were not clearly stated, but Perreault et al.
(2019) sought to determine the relationship between development of normoglycemia in
prediabetic participants and the prevalence of microvascular disease. The researchers
also studied whether the lower prevalence of microvascular disease was related to lower
cumulative glycemic exposure. Perreault et al. (2019) did not utilize a theoretical
framework for this study.
During the DPP, participants in twenty-seven U.S. research centers were
randomized into three groups: intensive lifestyle intervention, Metformin, or matching
double-blind placebo. The participants were adults who were overweight or obese (BMI
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≥24) and had a diagnosis of prediabetes (fasting plasma glucose 95-125mg/dl and 2-hour
plasma glucose 140-199mg/dl). The DPPOS consisted of 85% (2775 participants) of the
original cohort from the DPP, with a median follow up of fifteen years. The measured
outcomes of the DPPOS were development of diabetes or regression to normoglycemia,
and the prevalence of aggregate microvascular disease which was defined as one or more
of the following: retinopathy, neuropathy, and nephropathy (Perreault et al., 2019).
Currently, the recommendations for managing prediabetes focus on behavior
modification and weight loss. Perreault et al. (2019) with the DPPOS found that of the
participants in the group assigned to intensive lifestyle modification there was a 31%
increased risk of developing diabetes for those who did not regress to normoglycemia
during the DPP when compared to the placebo group. Approximately one-third of the
participants in the DPP returned to normoglycemia at some point during the program, and
this was associated with lower risk of aggregate microvascular disease development. The
researchers noted the relationship between aggregate microvascular disease and
regression from prediabetes to normoglycemia and found that there was a 22-30% lower
prevalence of microvascular disease in these participants who achieved normoglycemia.
In models adjusted for age, sex, race/ethnicity, and baseline A1C, regression to
normoglycemia was associated with lower prevalence of aggregate microvascular disease
(p=0.005); this relationship was also found in the univariate model (p<0.001) and
treatment group model (p=0.011). Despite these findings, the relationship between
achievement of normoglycemia and lower rates of microvascular disease was not
significant in models considering average A1C over time (p=0.63) or follow up diabetes
status (p=0.40). Average baseline A1C (5.96 ± 0.51) and follow up A1C (6.10 ± 0.70)
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for patients who never achieved normoglycemia during the DPP were significantly higher
than those of participants who regressed to normoglycemia during the DPP at baseline
(5.81 ± 0.47) and at follow up (5.76 ± 0.49) (p<0.0001).
During follow-up, the relationship between A1C and prevalence of aggregate
microvascular disease was studied, and the risk of developing aggregate microvascular
disease increased from 10% to nearly 80% across the A1C range of 4-11%. As the A1C
range increased, the prevalence of nephropathy also increased to 40% at an A1C of 11%.
For A1C <6% the prevalence for retinopathy was <10%; however, at A1C of >6% the
prevalence increased sharply and at A1C of 11% the prevalence of retinopathy was 65%.
The researchers found that peripheral neuropathy prevalence was approximately 12%,
and it did not differ across A1C ranges from 4-11%. The researchers concluded that
when DPP participants transitioned from prediabetes to normoglycemia, there was a
decreased prevalence of aggregate microvascular disease, particularly retinopathy and
nephropathy (Perreault et al., 2019).
Perreault et al. (2019) noted that a strength of the DPPOS was that the study
provided longitudinal outcome data of a large, well-described cohort who participated in
the DPP. One of the limitations of the DPPOS is that it was an observational study
conducted post-intervention of the DPP. For the participants who were confirmed as
diabetic during the DPP, the DPPOS did not reassess those participants’ glycemic status
which could have regressed back to normoglycemia. The methods for assessing for
microvascular disease were not standardized, thus the results are not standardized. The
presence of a microvascular disease was not an exclusion criterion from participating in
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the DPP; therefore, participants may have had microvascular disease prior to beginning
the DPP, which would alter the results and limit the findings of the study.
Perreault et al. (2019) utilized generalized estimating equations to examine the
prevalence of aggregate microvascular disease in participants who achieved
normoglycemia during the DPP. Individual relationships between normoglycemia and
the presence of retinopathy, nephropathy, and neuropathy were established using logistic
regression models. The relationship between follow-up A1C and microvascular disease
were described using generalized additive models. Perreault et al. with the DPPOS
indicates the need for early detection and intervention to prevent complications of
prediabetes. Therefore, patients must be tested, and PCPs must intervene early in the
disease process for best outcomes (Perreault et al., 2019).
Whitley, Hanson, and Parton used a prospective longitudinal study to compare
diabetes screenings between standard practices vs. systematically offered point-of-care
(POC) hemoglobin A1c (HbA1c) tests in patients aged 45 years or older (Whitley,
Hanson, & Parton, 2017, p.162). Whitley et al. determined differences in identifying
unknown chronic hyperglycemia in a single-physician family medicine clinic (Whitley,
Hanson, & Parton, 2017, p.162). The researchers in this study intended to prove the
importance between using systematic point-of-care HbA1c testing versus the standard
practices that are being used.
The researchers used a standard practice arm and an active screening arm. The
standard practice arm evaluated 709 patients, with the final number being 324 after their
exclusion criteria. The active screening arm evaluated 689 patients, with the final
screening number being 164 after their exclusion criteria and configuration of patients
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who were unable to participate. Patients who met the inclusion criteria were those aged
45 years or older. Patients who were excluded from the study were patients who were
pregnant, had a past medical history of diabetes (type 1 or type 2), had an HbA1c test in
the past 12 months or had steroid use (injectable or oral) in the past 3 months (Whitley,
Hanson, & Parton, 2017, p. 162). After the patients verbally confirmed their eligibility,
they were offered a free POC HbA1c. The participants were mostly Caucasian and there
were more females than males. The age range of the participants ranged from 45-91
years of age. A body mass index of morbidly obese (BMI greater than 40), obese (BMI
30-40), overweight (BMI 25-29), and healthy weight (BMI 18.5-25) were used in
screening patients. In the active screening arm only 37% of patients had a HbA1c less
than 5.6%. This resulted in 53% having a HbA1c in the prediabetes range (5.7%-6.4%)
and 10% of patients having a Hba1c greater than 6.5% (Whitley, Hanson, & Parton,
2017). The glycemic outcomes were compared between the active and standard practice
arms. The X² analysis method showed that the glycemic outcomes vs methods (active vs
standard) were statistically different from one another (p=0.005) (Whitley, Hanson, &
Parton, 2017 p. 163).
This study by Whitley et al. (2017) concluded that 63% of patients who were
systematically screened were unknowingly living in chronic hyperglycemia states
compared to 41% under standard practice testing. The researchers also noted that in
standard practice, blood glucose was the most common screening method used. HbA1c
is durable and more accurately reflects sustained hyperglycemia over a 3-month period as
compared to fasting or random glucose (Whitley, Hanson, & Parton, 2017, p. 163-164).
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Overall, the researchers presented a thorough article with research that directly
relates to the importance of screening systematically to diagnose prediabetes and
diabetes. The researchers noted that they did not investigate what influenced or
prevented the clinicians from screening patients. Future research areas identified
included (1) how to improve screening programs for chronic hyperglycemia, (2) methods
to facilitate glycemic curve, and (3) benefits of these screening and health initiatives on
outcomes, including reductions in microvascular complications, economic cost impact,
and change in quality of life (Whitley, Hanson, & Parton, 2017, p. 164).
Whitley et al. highlights the number of patients going undetected with prediabetes
due to the lack of screening. The current research interests focus on whether primary
care providers are screening according to the American Diabetes Association guidelines,
which requires PCPs to diagnose patients who are overweight or obese with one or more
additional risk factors for prediabetes using HbA1c testing. This study proves that
diagnosis by glucose alone may initially be missed until the glycemic curve fully shifts
upward, crosses the diagnostic threshold, and bothersome symptoms develop, impacting
quality of life. (Whitley, Hanson, & Parton, 2017, p. 164).
HbA1c may be the superior screening method because it can effectively identify
individuals at risk early on in the disease process. The data collected in this study clearly
shows that systematically screening for prediabetes with HbA1c in patients who are
overweight or obese, in age range, or have one or more risk factors set forth by the
American Diabetes Association, have a better outcome and are diagnosed as prediabetic
earlier. Diagnosing patients with prediabetes early in the disease process provides the
patients with a far better prognosis, including less microvascular changes and ultimately
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give the patients more control over their long-term health with diabetes. The results of
this study show that further education on following current guidelines, systematically
screening, and the importance of HbA1c testing versus blood glucose are imperative to
providing the best of quality of care for patients (Whitley et al., 2017).
Interventions
Stentz, Brewer, Wan, Garber, Daniels, Sands, and Kitabchi (2017) performed a
randomized, controlled trial for the purpose of assessing the effect of a high protein (HP)
diet versus a high carbohydrate (HC) diet, on remission of prediabetes to normal glucose
tolerance. Obese, prediabetic, male and female subjects were evaluated after undergoing
6 months of dietary interventions. Researchers also looked at insulin sensitivity, weight
loss, lean and fat body mass changes, inflammatory markers, and cardiovascular risk
(CVR) factors of the subjects. According to the Centers for Disease Control and
Prevention (CDC) National Diabetes Statistics Report of 2014, there are 29.1 million
people with diabetes, 8.1 million of which are undiagnosed. Obesity is the most
prevalent risk factor for diabetes with 90% of diabetics being either overweight or obese
(Stentz et al., 2017).
Treatment of obesity plays a vital role in the prevention or delay of diabetes and
treatment of those diagnosed with prediabetes. Studies have shown that reductions in
obesity lead to improved glycemic control and overall health. Per the American Diabetes
Association (ADA) guidelines, any one of the following labs are diagnostic for
prediabetes: A1c 5.7-6.4%, fasting plasma glucose (FPG) 100-125mg/dL, or 75-g oral
glucose tolerance test (OGTT) 140-199mg/dL. The ADA recommends diet and exercise,
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as well as the consideration of prescribing Metformin as the standard of care for
prediabetes. Metformin has side effects and is often needed long term. Therefore, this
study is focused only on the benefits of a HP diet over a HC diet on remission of
prediabetes to normal glucose tolerance, insulin sensitivity, weight loss, lean and fat body
mass changes, inflammatory markers, and CVR factors of the subjects included in the
study. There was no theoretical framework identified in this study.
The research objective being analyzed in this study by Stentz et al. (2017)
included determining the effect of a HP diet vs a HC diet on the remission of prediabetes,
the effects on metabolic parameters, and the effects on lean and fat body mass after 6
months of dietary interventions. The results of this study were intended to provide
education and research on the effectiveness of HP dietary interventions in accomplishing
remission of prediabetes to normal glucose tolerance (NGT).
This study was conducted at the General Clinical Research Center (GCRC),
which is where all participants were seen weekly during the study. Of the 223 subjects
that were screened by phone, 178 of them signed a consent to participate. There was an
extensive list of exclusion and inclusion criteria resulting in only 38 subjects meeting
all of the criteria to be included in the study. The subjects were randomized into diet
groups to include 18 subjects in the HP group and 20 subjects in the HC group. Of the 38
participants, 14 total subjects dropped out within a few weeks leaving 12 subjects in each
group that completed the 6-month study. Independent variables included the HP diet and
the HC diet. Dependent variables included the participant’s test results upon completion
of the study. This study was approved by the Institutional Review Board of the
University of Tennessee Health Science Center (UTHSC) (Stentz et al., 2017).
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At baseline all subjects underwent a history and physical (H&P), height, weight,
blood pressure (BP), waist circumference, standard OGTT, mixed meal tolerance test
(MTT), and multiple other lab and diagnostic tests. Each participant’s caloric needs were
determined based on their resting metabolic rate (RMR), then 500kcals/day were
subtracted to promote a weight loss of 1-2 lbs. a week. Subjects were then given a diet
plan and either HP or HC pre-packaged frozen meals, three meals a day plus snacks were
provided. The subjects had some choices regarding their meals but were expected to
follow the meal plan once it was given to them. They were weighed and picked up their
meals and daily menu record at their weekly visits to GCRC. At the end of the 6-month
trial, the subjects were re-assessed, and all lab and diagnostic testing were repeated for a
comparison analysis (Stentz et al., 2017).
Statistical analysis was conducted with SAS V.9.3 (SAS Institute, Cary North
Carolina, USA), utilizing the Wilcoxon rank-sum test and the Wilcoxon signed-rank test.
The main outcomes examined included the remission of prediabetes, insulin sensitivity,
CVR factors, inflammatory cytokines, and changes in lean and fat mass with comparison
from baseline to 6 months post trial. At baseline, the two groups were not statistically
different. However, at 6 months, the HP diet group had a 100% remission of prediabetes
to NGT, compared to the HC diet group with only a 33% remission. Remission of
prediabetes to NGT is considered if the subject at 6 months meets both of the following:
FPG <100mg/dL and a 2-hour OGTT <140mg/dL. Both groups had significant weight
loss. The HP group showed significant improvement over the HC group regarding
HgA1c and insulin sensitivity also. CVR factors were reduced in both groups; the HP
group showed a greater reduction. The HP group showed greater improvement in insulin
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sensitivity and glucose disposal evidenced by the OGTT and insulin results. On both the
OGTTs and MTTs, the HC group had higher glucose and insulin levels at 6 months. The
HP group showed a significant increase in lean mass (LM) % and a decrease in fat mass
(FM) %; whereas the HC group showed a decrease in both the LM and FM (Stentz et al.,
2017).
Stentz et al., 2017, reported the strengths of this study, which included a
randomized control trial with all food and diet plans being provided at weekly visits.
This is also the first study on lifestyle interventions that showed at 100% remission of
prediabetes, and the use of adjustable diet plans for approximately $13 per day.
Identified weaknesses included a small sample size and a possible limitation due to the
testing method used with African Americans in regard to insulin sensitivity.
This study will benefit the current research project by providing data to support
the use of a HP diet in those diagnosed with prediabetes as part of the lifestyle
modifications that are recommended by the ADA to move patient from prediabetes to
normal glucose tolerance. In the current research, we are examining interventions
utilized or implemented by the PCP for treatment or management of prediabetes
including diet and nutrition education. This article is relevant to the current research
interest in that it shows 100% remission of prediabetes to normal glucose tolerance with
the use of the HP diet. Participants on the HP diet showed significant improvement in
insulin sensitivity (p=0.001), cardiovascular risk factors (p=0.04), inflammatory
cytokines (p=0.001), oxidative stress (p=0.001), and increased lean body mass percentage
(p=0.001), at 6 months compared to the HC diet participants (Stentz et al., 2017).
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Moin, Damschroder, Youles, Makki, Billington, Yancey, and Richardson (2016)
proposed implementing an algorithm for overweight or obese veterans to be screened for
prediabetes. One in four veterans is diabetic, and some may be overlooked for screening.
Moin, et al. (2016) proposed that a prediabetes algorithm for overweight or obese
veterans may increase screening practices. Type 2 Diabetes prevention is a national goal
for the Veterans Health Administration (VHA).
Moin, et al. (2016) conducted an implementation project with the Veterans
Affairs (VA) Diabetes Prevention Program (DPP) between 2012 and 2015. Information
was gathered from the VHA through electronic medical records (EMRs) from 2012-2015.
Over the prior six to twelve months, interviews, and/or laboratory tests were used to
classify patient’s status as normal glycemic status, prediabetes, or diabetes. There was no
theoretical framework identified.
Moin, et al. chose a group of veterans who had attended orientation for MOVE!, a
weight loss program. In order to be considered in the study, the veterans must live less
than a one-hour distance from the testing facility and had to be referred, either by a
clinician or self-referral. The veteran also had to have a BMI of 25 or more and one
additional obesity-related conditions, such as hypertension (HTN). Moin, et al. excluded
patients previously diagnosed as diabetic or prediabetic. The sample included 1,830
patients, at three Veterans Affairs Medical Centers (VAMCs), who were evaluated
including medical sites on the West Coast, Midwest, and East Coast.
Moin, et al. proposed an algorithm in which the different sites implemented in
different manners. All sites invited MOVE! participants to attended laboratory
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screenings if they had no prior history of prediabetes or diabetes. The laboratory
screening relied on A1C testing.
Moin, et al. found 29% (n=530) had normal glycemic status, 28% (n=504) were
prediabetics, and 43% (n=796) were diabetics. Normal glycemic patients were, on
average, 53 years of age with BMI of 34.8. Prediabetics were on average 58 years of age,
had a BMI of 34.8, and an A1C of 6.0. Diabetics were, on average, 61.5 years of age and
had a BMI of 37.1. Comorbidities occurred more frequently among diabetic patients than
normal glycemic status patients.
Moin, et al. discussed multiple different points to be considered. They felt
population-wide diabetic screening was lifesaving, despite being controversial. They
discussed the need for considering when screening should take place and felt there was a
lack of awareness that prediabetes is a medical problem. Also, short office visits with
long problem lists could result in decreased priority on prediabetic screening. Each of
these points of discussion were valid considerations.
Moin, et al. found multiple limitations to their study. First, they found that lack of
confirmatory testing limited validation. Next, they found that their population only
included mostly male Veterans. Lastly, they found that using only Veterans who
attended MOVE! program orientation may have excluded other high-risk Veterans, as
many may not have been referred or attended the MOVE! orientation. Although there
were limitations, this study did produce an increase in screening based on the algorithm.
The current research project examining prediabetes screening practices in
overweight individuals will help providers understand gaps in early diagnosis and
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management of prediabetes. Secondly, as included in the current research, Moin, et al.
excluded patients with a history of diabetes and prediabetes. Next, the current research
also includes a population with a BMI above 25. Current research also includes A1C as
its chosen screening practice, as in this study. Lastly, this study will answer the question
of if primary care providers testing for prediabetes with A1c for all adult patients that are
overweight or obese and have one or more risk factors (first degree relatives with
diabetes, hypertension (blood pressure above 140/90), high risk race or ethnicity, or
history of cardiovascular disease (stents, myocardial infarction, angina).
Theoretical Framework
Nola Pender’s Health Promotion Model (HPM) is a theoretical model that
“depicts the multifaceted natures of persons interacting with their environment as they
pursue health” (Pender, 1996). This theory proposes that an individual’s past experiences
and personal factors impact health promoting behaviors. The HPM considers the
following factors and their relationship to the development of a health promoting
behavior: prior related behavior; personal factors, including biological, psychological,
and sociocultural; perceived benefits; perceived barriers; perceived self-efficacy; activityrelated affect; interpersonal influences; situational influences; commitment to plan; and
immediate competing demands and preferences (Pender et al., 2006).
Two examples of how the HPM can be used in research and in patient care are the
Health Promoting Lifestyle Profile (HLPL) and the Exercise Benefits-Barriers Scale
(EBBS), which were developed using the HPM as a basis. These instruments are utilized
by health care providers to assess health promoting lifestyle characteristics of patients
and to educate patients in this area (Pender et al., 2006).
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Primary care providers (PCP) are involved in the HPM by empowering the patient
through education and development of an action plan to alter the environmental
influences and perceived barriers to action. Benefits of using the HPM in practice are
that it is applicable across the lifespan, and it is suitable for use in numerous settings.
The goal of the HPM is to empower patients to overcome perceived barriers, competing
demands, situational influences, and interpersonal influences to achieve a health
promoting behavior (Pender et al., 2006).
The HPM was utilized in two of the following research articles to gain better
understanding of health promoting behaviors in urban black women and in urban
adolescents (Hepburn, 2018; Norris & Ayres, 2016). Eden, Orleans, Mulrow, Pender, and
Teutsch, as part of a panel of experts for the United States Preventative Services Task
Force (USPSF), studied the effects of PCP counseling on adults and its effect on
development and maintenance of physical activity over the long-term which is a health
promoting behavior (Eden et al., 2002).
In a study conducted by Norris and Ayres on the theoretical relationship between
psychosocial factors and health promoting behaviors of adolescents, the researchers
recognized that behaviors developed during adolescence will affect a person throughout
his or her life. During this developmental phase, it is critical to begin health promoting
behaviors early to avoid development of preventable disease in adulthood. Researchers
guided their study by using Nola Pender’s HPM. The researchers focused their study on
the relationship between the specific health promoting behavior of physical activity and
the following psychosocial factors: perceived benefits, perceived barriers, self-efficacy,
parent social support, and friend social support (Norris & Ayres, 2016).
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Norris and Ayres hypothesized that “perceived benefits (BE), self-efficacy (SE),
parent social support (PS), and friend social support (FS), are positively related to healthpromoting physical activity behaviors (HPB) in urban adolescents, and perceived barriers
(BA) are negatively related to health promoting physical activity (HPB) in urban
adolescents” (Norris & Ayres, 2016, p. 17-18). The study was a correlational research
design conducted in an urban high school with a diverse population of 108 participants
who were fluent in English and enrolled in grades 10-12. The sample of participants was
selected using a convenience sampling strategy. Once parental signed consent and
student verbal assent were received, the participants were given a questionnaire, which
included demographic information and the Adolescent Lifestyle Profile (ALP-R2) which
is a modified version of the Health Promoting Lifestyle Profile II (HLPL-II). This
instrument was used to measure the relationship between independent variables (BE, BA,
SE, PS, and FS) and physical activity as a health promoting behavior (Norris & Ayres,
2016).
Of the participants in the study, 45.4% were male and 54.6% were female with
the mean age of 16.9 years. The sample included 41.1% African Americans, 37.4%
Caucasians, 19.6% Hispanic, and 1.9% Asian Americans, and according to school level
socioeconomic data, approximately two-thirds of the students were from lowsocioeconomic backgrounds. Relationships between the independent variables of
perceived benefits, perceived barriers, self-efficacy, parent social support, and friend
social support with development of health promoting behaviors were calculated using
Pearson’s correlation and multiple regression analysis. The results of the study support
the researchers’ hypotheses and “positive relationships were found between BE (r=0.580,
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p=0.000), SE (r=0.599, p=0.000), PS (r=0.519, p=0.000), FS (r=0.670, p=0.000), and
HPB, whereas a negative relationship was found with BA and HPB (r= -0.474,
p=0.000),” (Norris & Ayres, 2016, p. 19). Norris and Ayres concluded that the five
psychosocial factors tested were significant indicators of development of healthpromoting behaviors. Friend social support was the most predictive, and parent social
support was the least predictive of development of a health-promoting behavior in
adolescents. A strength of this study was that the sample represented minority and lowincome adolescents, which recent research suggests has disparities in health-promoting
behaviors. The importance of establishing health promoting behaviors in adolescence is
of vital importance to prevent disease development and progression in adulthood (Norris
& Ayres, 2016).
Health-promotion behaviors among urban black women were studied by Hepburn
for the purpose of gaining a better understanding of the variables that affect these
behaviors. Hepburn’s study focused on the following research question: “What are the
relative contributions of health literacy, self-efficacy, and readiness for change to health
promotion behaviors in urban Black women?” (Hepburn, 2018, p. 3). The study was
guided by Nola Pender’s HPM, and the specific psychosocial factors that were assessed
from the HPM were self-efficacy and development of health-promoting behaviors
(Hepburn, 2018).
This study was a nonexperimental descriptive cross-sectional study, which
included a sample of 132 black women between the ages 30-64 living in a U.S.
metropolitan area. Data was collected using pen-and-paper surveys at the Clinical
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Translational Science Center at Bellevue Hospital in 2015. The survey included a
demographic profile, a health literacy instrument (Newest Vital Sign, [NVS]), a selfefficacy scale (New General Self-Efficacy Scale, [NGSE]), a readiness for change
questionnaire (Health Risk Instrument, [HRI]), and health promotion behavior profile
(Health Promotion Lifestyle Profile II, [HLPL-II]). Data analysis included correlation of
study variables using Pearson correlation statistic. Spearman’s rho was used to describe
the relationship between responses of obese participants (BMI≥30) and normal weight
participants (BMI<25) (Hepburn, 2018).
Of the participants in the study conducted by Hepburn, 43.2% were obese, 29.9%
were overweight, and 23.1% were normal weight. In this study, obesity (BMI≥30) was
correlated with fewer health promotion behaviors and obese participants were “less likely
to seek regular medical care (rs=-.316, p < .05) or control their hypertension
(rs= -.297, p < .05) than those with a normal BMI” (Hepburn,2018, p. 8). Hepburn
reports that 57.6% of participants scored low on the HLPL-II which indicates that they
are less likely to engage in health promotion activity; and therefore, these participants
were more likely to suffer from hypertension (rs= -.120, p < .05) and to be prescribed
anti-hypertensive medications (rs= -.005, p < .05). Low HLPL-II scores were correlated
with diets low in fruits and vegetables (rs= -.114, p < .05) and with lack of regular
exercise (rs= -.162, p < .05); on the other hand, participants with high HLPL-II scores
were more likely to exercise regularly (rs= -.365, p < .001). Hepburn reported that health
literacy was limited or inadequate in 67% of the study’s participants. Participants’
readiness for change was assessed using the HRI and the results indicated that 67% of
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participants would like to change but are not actively involved in changing (Hepburn,
2018).
Hepburn concluded that a participant’s health literacy, self-efficacy, and readiness
to change were related to participation in health promoting behaviors (p< .001); with the
most significant correlation existing between readiness for change and health promotion
behaviors. The study population was similar demographically to the U.S. census
demographic statistics for black women; therefore, the results can be generalized to this
population. Due to the nature of the study, one limitation was that participants who were
illiterate or did not speak or read English were excluded; therefore, the sample may have
been affected. Hepburn suggested further research to explore the discrepancy between
BMIs in black and white women.
Eden, Orleans, Mulrow, Pender, and Teutsch conducted a study to examine
whether physical activity counseling provided to adults in primary care settings was
effective in improving and maintaining physical activity levels. Since many of the
chronic diseases in the United States can be directly linked to a sedentary lifestyle, it is of
utmost importance that clinicians are involved in promoting physical activity.
The Healthy People 2010 guidelines recommended that adults should engage in
“30 minutes of moderate activity on 5 or more days per week or 20 minutes of vigorous
activity three or more times per week” (Eden et al., 2002, p. 208). Despite this
recommendation, only 25% of Americans actually achieve that goal and 29% of
Americans report participating in no regular physical activity. In 1996, the United States
Preventative Services Task Force (USPSF) recommended that clinicians counsel patients
on increasing physical activity levels based on the evidence that increased physical
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activity is beneficial to overall health and disease prevention. Eden et al. prepared this
study for the USPSTF to address the following questions: “Do adults counseled by
primary care clinicians improve or maintain physical activity behavior?” and “If so, what
types of interventions are most effective?” (Eden et al., 2002, p. 208).
The review conducted by Eden et al. was a systematic review of controlled trials,
case-control studies, and observational studies, which were conducted between 1994 and
March 2002. These were found either in the Cochrane Database of Systematic Reviews,
the Registry of Controlled Trials, MEDLINE, Healthstar, or Best Evidence databases. Of
the studies found, seven randomized controlled trials and one non-randomized control
trial met the inclusion criteria for this review.
The studies were analyzed by the researchers and rated as “good,” “fair,” and
“poor.” Two of the studies were considered “good,” five were considered “fair,” and the
other was deemed “poor;” and it was excluded from the review. Data was abstracted
from the included studies and information regarding “setting, patient participants,
providers, interventions, adherence, and outcomes” was reviewed (Eden et al., 2002, p.
209). Of most interest to Eden et al. was “the proportion of patients who met the Healthy
People 2010 goal in the ‘long term’” which was defined as 6 months after randomization
(Eden et al., 2002, p. 209).
In this review, six of the studies indicated that counseling for increasing physical
activity was either modestly effective or not effective at all at 6 to 24 months. Two of the
trials demonstrated no effect on physical activity from counseling at 6 or more months.
Three of the studies in this review addressed multiple behaviors, including physical
activity, with two of these studies reporting short and long-term adherence to increased
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physical activity. However, the results indicate an increase in the number of exercise
sessions or in time spent exercising, not at increase in the number of participants
engaging in physical activity. The interventions that were related to increased adherence
were a written prescription for physical activity and more intensive counseling
interventions for women than men (Eden et al., 2002).
Data reviewed by Eden et al. provided limited details on the counseling
intervention, follow-up rate, baseline differences in physical activity, and provider
adherence to counseling; therefore, the results of this review do not clearly relate
clinician counseling to increased physical activity in patients. Eden et al. determined that
“although research suggest that counseling can be effective in some specific situations,
the evidence is insufficient to generally conclude that counseling is effective” (Eden et
al., 2002, p. 214).
The Health Promotion Model will be used in guiding this study to better
understand the relationship between providers and patients in a collaborative effort to
achieve better health. The provider must be knowledgeable on current screening
regulations, diagnostic criteria, and treatment practices to be able to service their
population. The patients are encouraged to take control of their care by utilizing
information provided to lessen their chances of developing possible life-threatening
diseases. During this research project, the researchers hope to recognize high-risk
populations, identify screening practice service failures, and single out where care and
education have been lacking. This research will help guide and reinforce the education of
providers in standards of practice to ensure the best possible care is being provided. With
early testing, planning, and lifestyle modification, providers can play a vital role in
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decreasing the risk of transition from prediabetes to diabetes. With this proactive
treatment plan of high-risk populations, PCPs can enact change that targets that
population to reduce risks of diabetes, which will decrease chances of diabetic related
complications.
Summary
The research articles were gathered to support the relevance of the current
research project. The research data worksheet was formed following a thorough review
of the literature and the ADA guidelines for prediabetes. This data worksheet was used
to assess prediabetes testing practices among PCPs in Mississippi. The current research
showed there is a deficit in adequately testing for prediabetes. Many barriers like patient
compliance and insurance coverage attributed to physicians not properly testing patients.
The primary intention in surfacing current research was to allow primary care providers
to evaluate whether they were appropriately screening patients for prediabetes.

Chapter III
Methodology
The Centers for Disease Control and Prevention (CDC) estimate that 12.2% (30.3
million) of American adults have diabetes and that 7.2 million of those people are
undiagnosed (CDC, 2015). In Mississippi, diabetes affects 13.6% of the population
(308,295), and the state has the highest rate of diabetes in the country (CDC, 2015).
High-risk patients are patients who are overweight or obese and have certain
comorbidities including, but not limited to, CVD and essential hypertension. These highrisk patients should be diligently tested for prediabetes and educated on lifestyle
modification techniques that will decrease their chance of becoming prediabetic or
diabetic.
The purpose of this study was to determine if primary care providers were
performing A1C testing for prediabetes for patients 18 and older that are overweight,
obese, or have a BMI that is 25 or greater and have additional risk factors for prediabetes.
The purpose of this study was also to determine if patients who are 45 or older without
further risk factors were being tested appropriately according to ADA guidelines. Of the
patients found to have been tested, the researchers determined if lifestyle modifications
and/or prescriptions were being provided to prevent prediabetes or to prevent transition
from prediabetes to diabetes.
Design of the Study
The researchers utilized a nonexperimental, quantitative research design utilizing
retrospective chart reviews to determine if primary care providers were adhering to ADA
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guidelines for testing overweight and obese patients for prediabetes. The study focused
on the following two adult populations: overweight and obese adults with an additional
risk factor for diabetes and adults over 45 years old with or without risk factors. The data
collection worksheet was utilized by the researchers to determine if these populations of
patients were tested appropriately, diagnosed according to ADA guidelines for
prediabetes, and treated according to the ADA guidelines for prediabetes. The
researchers also determined if patients age 45 years and older were being tested
according to ADA guidelines. Data was collected by accessing electronic medical
records (EMRs) using systematic sampling of adult patients age 18 years or older. The
researchers collected data by accessing charts in five primary care clinics in Mississippi.
The researchers determined, in those confirmed to be prediabetic, if they were receiving
treatment and/or lifestyle modifications on prevention of transition to diabetes.
Research Setting
This study took place in five primary care clinics in Mississippi. The researchers
gathered data between the hours of 8 a.m. and 5 p.m. under staff supervision.
Population and Sample
This study took place in five primary care clinics in Mississippi. The first target
population was patients who were 18 years and older, who were considered obese or
overweight based on diagnosis code or BMI who also presented with one or more risk
factors for CVD or a diagnosis of Essential Hypertension. The second target population
was patients who were 45 years and without other risk factors. The researchers
conducted a retrospective chart review on electronic medical records of adult patients
aged 18 years or older using a systematic sampling technique. Charts were selected
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based on inclusion dates of January 1, 2019 to December 31, 2019 and age ≥18 years.
From this list, systematic sampling was utilized; every 5th chart was included in the study,
totaling 100 charts per clinic. Once the EMRs were selected for the study, the
researchers utilized a data collection worksheet to determine if those EMRs met inclusion
criteria for the study of: age ≥18 with either a diagnosis of overweight or obesity or BMI
>25 and presence of additional risk factors of hypertension or cardiovascular disease, or
age ≥45 with no BMI requirement and no additional risk factors. The systematic
convenience sample originally consisted of 500 charts, which divided up to 100 from
each clinic. Of those, 434 met the above requirements.
Protection of Subjects
Approval was obtained from the Mississippi University for Women Institutional
Review Board prior to data collection. Data was gathered through retrospective chart
reviews that included no direct patient contact. Data collected remained confidential and
in the sole possession of the researchers and did not contain any personal or identifiable
information. Because the study was completed through retrospective chart reviews, it
included no risk or direct benefit to the patients. Informed consent was obtained by every
clinic manager where the study took take place. At the conclusion of the study, all forms
of data collection were shredded and permanently erased.
Methods of Data Collection
The researchers reviewed 100 charts each from five primary care clinics in
Mississippi to determine if primary care providers were testing, treating, and educating
patients that are 18 years and older who were confirmed to be obese or overweight and
had risk factors for CVD or a diagnosis of essential hypertension. There was also a
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secondary population to determine if patients who were 45 years and older with no
identifiable risk factors were being tested, treated, and educated, as well. The researchers
utilized the data collection worksheet to examine the testing practices of PCPs by
reviewing documentation in the medical record between January 1, 2017 and December
31, 2019. Data was collected between 8 a.m. and 5 p.m. in each of the five clinics while
under staff supervision. Charts were included if they met the inclusion criteria for the
study listed above. Exclusion criteria included patients under the age of 18 years old,
patients who were pregnant during time of study, and patients who had a previous
diagnosis of diabetes. The researchers collected all necessary data in one day utilizing
the EMR. The data was recorded on a data collection worksheet that consisted of
inclusion criteria and applicable continuum of care results.
Methods of Data Analysis
The researchers designed a data collection worksheet that was utilized for the
chart reviews. The data collection worksheets included the following information: age,
gender, race, provider type, payor source, diagnosis, testing, and treatment/education.
The data was analyzed using descriptive statistics including, but not limited to, frequency
distributions and percentages. The data was analyzed using SPSS 26 software. Chisquare testing of independence was also conducted to discover if there were any
relationship between categorical variables. Data was analyzed for provider adherence to
ADA guidelines for testing and treatment of patients that are considered high risk for
developing diabetes.
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Summary
The researchers assessed whether PCPs in Mississippi were testing for prediabetes
according to the ADA guidelines. The researchers determined, in those confirmed to be
prediabetic, if they were receiving treatment and/or lifestyle modifications on prevention
of the transition to diabetes. The researchers also determined if patients age 45 years and
older were being tested regardless of BMI according to ADA guidelines. The researchers
gathered their data within clinic business hours of 8 a.m. and 5 p.m. under staff
supervision. The researchers utilized a randomized sample of 100 patients from five
different clinics in Mississippi. The researchers also maintained patient privacy and
protection by maintaining confidentiality and properly disposing of any data collected
after the study was completed. Data was analyzed including patient demographics,
research criteria, and treatment options listed above that adhere to ADA guidelines.

Chapter IV
Presentation of Findings
Left untreated, prediabetes can progress to diabetes. Progression to diabetes can
impose an astronomical burden. Diabetes complications may go unnoticed because
patients may be asymptomatic, and significant damage may have already occurred by the
time they are diagnosed (Cowie, 2019). With screening practices of overweight and
obese patients, the level of undiagnosed prediabetes and damage from undiagnosed
diabetes can be reduced. The American Diabetes Association (ADA) has published
Standards of Medical Care in Diabetes to guide patient care for those at risk for
developing diabetes or who have already developed diabetes. The guidelines state that
overweight and obese adults with one or more risk factors should be screened (ADA,
2019).
The primary goal of this study was to evaluate Mississippi primary care
providers’ (PCPs) screening practices for prediabetes in patients 18 years or older who
are overweight or obese with one or more risk factors, as well as those 45 or greater with
or without risk factors. The risk factors examined were angina, MI, coronary stents, and
hypertension. After determining screening practices, the study further examined PCPs’
management of prediabetes. The management practices examined were if the PCP
prescribed Metformin and/or lifestyle modifications (diet/exercise) on patients identified
as prediabetic.
A nonexperimental, quantitative research design utilizing retrospective chart
reviews in five different primary health clinics in Mississippi was used to evaluate the
research questions. All charts reviewed were electronic medical records. The patients
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were systematically selected, were 18 years or older, obese or overweight, and had at
least one additional risk factor for diabetes. Also, patients > 45 years old were included
with no body mass index (BMI) or risk factor requirements. Pregnant women and
patients with previous diagnoses of diabetes were excluded. The data was collected from
charts dated January 1, 2019 – December 31, 2019. Further information collected
included patient demographics (age, gender, race, and payor type), provider type,
diabetes diagnosis history, A1C screening, A1C result, and interventions. Although 500
patient charts were reviewed as initially proposed, only 434 patient charts were included
due to the exclusion criteria.
Participant Profile
Age: The sample population was divided into 18-44 years of age and 45 years of
age or older. Of the sample population, 38.2% were 18-44 years of age. The remaining
61.8% of sample population were 45 years of age or older.
Gender: The sample population was divided into male and female. Of the
sample population, 42.4% were male. The remaining 57.6 % of the population were
female.
Race: The sample population was divided into African American, Caucasian,
and other. The sample population was 30.9% African American, 65% Caucasian, and
3.9% other race.
Provider type: The provider categories were divided into Nurse Practitioner,
Medical Doctor, Doctor of Osteopathy, and Physician Assistant after data collection, the
categories were narrowed to Medical Doctor and Nurse Practitioner. The providers were
72.8% Nurse Practitioners and 27.2% Medical Doctors.
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Payor Source: The Payor sources were divided into Medicare/Medicaid,
Commercial, Private Pay, and none. Medicare/Medicaid made up 29.7%, Commercial
made up 60.8%, Private pay made up 4.8%, and None made up 3.7%.
Overweight, Obese, or BMI >25: Within the last three years, has the patient
been diagnosed as overweight, obese, or have a BMI >25? The criteria were broken into
yes and no. The results indicated 74.3% were diagnosed as obese, overweight, or had a
BMI of 25 or more within the prior 3 years. The results indicated 25.7% had no
diagnosis of overweight, obese, or BMI greater than 25 within the prior 3 years.
Age >18 years with one or more risk factor: Is the patient >18 years of age
with one or more risk factor for CVD or Essential Hypertension? The categories were
broken into yes and no. It was found that 13.8% had risk factors of CVD or Essential
Hypertension, and it revealed 86.2% did not have one or more risk factors for CVD or
Essential Hypertension.
Age > 45: Is patient >45? The patient sample revealed that 61.8% of the patient
population was 45 years or older, and 38.2% were younger than 45 years of age.
A1C: Was an A1C completed? The sample population revealed that 35.3 % of
the population were screened by A1C, 40.6% were not screened, and 24.2% were not
recorded.
A1C Result: Did A1C fall between 5.7%-6.4% (prediabetes)? The sample
population revealed 19.1% of the population A1C screenings fell within the prediabetes
range (5.7%-6.4%), 15.9% of the population were screened and did not have an A1C
within the prediabetes range, and 65% were not recorded.
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Interventions Implemented: If prediabetes was indicated, what interventions
were implemented? Lifestyle modifications were initiated in 22.5%, Metformin were
initiated in 53.5%, and both Lifestyle modifications and Metformin were included in
23.9% of the sample populated who were screened and revealed to be diagnosed with
prediabetes.
It was determined that A1C screening was necessary in 74.7% of the population,
according to the guidelines.
Findings
The total sample population included 434 patients. Of the 434, 342 (74.65%) met
the ADA guidelines for testing. Of the 324 who met the testing guidelines, 149 (34.33%)
were tested. There were 166 patients who were in the 18-44 age range, and 103 patients
out of the 166 had a diagnosis of obesity, overweight, or a BMI over 25. Of the 103, 56
(33.73%) had an additional risk factor for diabetes.
Research Question 1: Are primary care providers testing for prediabetes using
the A1C of overweight or obese patients ages18 years old or older and have one or more
of the following additional risk factors for prediabetes, history of CVD (angina, MI, or
coronary stents) or a diagnosis of Essential Hypertension?
In this study, of the 18-44-year-old range (N=166), 56 (33.76%) met the testing
guidelines. Of the 33.76% that met the criteria, 21 (37.5%) were tested.
Research Question 2: Are primary care providers testing for prediabetes using
the A1C of patients 45 years old or older, regardless of risk factors?
Of the 268 patients who were 45 years old or older, 128 (47.76%) of them were
tested.
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Research Question 3: For prediabetic patients with A1C results between the
ranges 5.7% -6.4%, are PCPs prescribing Metformin and/or lifestyle interventions?
The ADA recommends lifestyle modifications such as diet, exercise, and/or
weight loss as well as medication management (Metformin) to decrease the risk of
progression from prediabetes to diabetes. The study revealed 83 patients identified in the
sample population as prediabetic. Of the 83 identified, 71 had an intervention recorded.
Trends among provider type: It is always intriguing to see the difference in
provider types and their screening practice differences. Nurse practitioners were the
provider type for 316 of the 434 sample patients. Medical Doctors were the provider type
for 118 of the 434 sample patients. For the patients in the 18 to 24 age group (N=166),
56 (33.76%) met the guidelines for testing. Of those that met the guidelines, only 21
patients were tested. Of the 21 patients that were tested, 15 of those patients were tested
by nurse practitioners and 6 by medical doctors. There was a total of 268 patients who
were 45 years of age and older. According to the testing guidelines, all of these patients
should be tested. Only 128 (47.76%) were tested for prediabetes. However, there were
no statistically significant differences in screening practices by provider type found in
this sample (p=0.449).
Interventions for those diagnosed as prediabetic: The study revealed that 83
patients identified in the sample population were prediabetic. Of the 83 identified as
prediabetic, 71 of those patients had an intervention recorded. Providers were broken
down by categories: 22.5% recommended lifestyle modifications, 53.5% initiated
Metformin therapy, and 23.9% used both lifestyle modifications and Metformin therapy.
Of the 71 patients, nurse practitioners provided 62 of those patients with lifestyle
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modifications, Metformin, or both (lifestyle modifications and Metformin); whereas,
medical doctors provided 9 patients with Metformin or both (lifestyle modifications and
Metformin).
Summary of Findings
The researchers’ findings from the retrospective review of 500 patient charts from
five different primary health clinics in Mississippi are presented in this chapter. The data
analyzed from the patient demographics and research questions are presented. There
were no statistically significant findings between provider types found in this sample.
However, this sample clearly shows that an A1C test was not completed when it was
needed, according to ADA guidelines. The data shows that a total of 324 (74.65%)
patients met the guidelines for screening and should have been screened; however, only
149 (34.33%) were screened. There was a total of 268 patients who were 45 years of age
and older and according to the ADA guidelines all of these patients should have been
screened; only 128 (47.76%) of those patients were screened. This study has shown that
there is a detrimental flaw in primary care providers screening practices for prediabetes in
Mississippi.

Chapter V
Summary and Conclusions
The primary goal of this study was to evaluate Mississippi primary care
providers’ (PCPs) screening practices for prediabetes in patients 18 years or older who
are overweight or obese with one or more risk factors, and those 45 or greater with or
without risk factors. The specific patient populations that were examined in this study
included two subgroups: patients between ages 18 and 44 who had a BMI ≥ 25 with one
or more additional risk factors including history of CVD (angina, MI, or coronary stents)
or a diagnosis of Essential Hypertension and patients 45 years of age and older.
According to the American Diabetes Association (ADA), these two subgroups should be
screened for prediabetes because they are at increased risk of developing diabetes. For
patients who are identified as prediabetic, the ADA recommends interventions to slow
disease progression, including lifestyle modifications (diet, exercise, and weight loss) and
medication management (Metformin) (ADA, 2019). This research study was guided by
the ADA guidelines for screening asymptomatic adult patients. The researchers used
Nola Pender’s Health Promotion Model (HPM) as the theoretical framework to guide this
study. The HPM, when utilized in primary care, allows the provider to educate,
empower, and promote the health of their patients, and consequently, prevent progression
of chronic disease (Sakraida, 2018).
In this study, the researchers conducted retrospective chart reviews in five
different primary care clinics in Mississippi. A systematic, convenience sample of 100
electronic medical records (EMR) from each clinic was obtained, and EMRs meeting
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inclusion criteria were included in the study. The sample size was 434. The researchers
used a data collection worksheet to obtain necessary information from the EMR.
Informed consent was obtained by all clinical managers prior to data collection. All data
collection was completed during regular business hours and under the supervision of
office personnel. Data collection was completed by researchers during March 2020.
Descriptive statistics were used to explain research findings including frequencies and
cross-tabulations. A chi-square test of independence was utilized to determine
relationships between variables and outcomes. Once data collection was completed, the
data collection worksheets were destroyed by shredding paper documents and/or deleting
electronic copies.
The data collection worksheet was used to gather necessary information to answer
the following research questions.
Are primary care providers testing for prediabetes using the A1C of overweight or
obese patients ages18 years old or older and have one or more of the following additional
risk factors for prediabetes, history of CVD (angina, MI, or coronary stents) or a
diagnosis of Essential Hypertension?
Are primary care providers testing for prediabetes using the A1C of patients 45 years
old or older, regardless of risk factors?
For prediabetic patients with A1C results between the ranges 5.7% -6.4%, are PCPs
prescribing Metformin and/or lifestyle interventions?
Interpretation of findings:
Five hundred charts were reviewed, and after exclusion criteria were applied, the
sample included 434 patient charts. The charts included in the study met inclusion
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criteria of ≥ 18 years of age and patients who had a diagnosis of diabetes or were
pregnant were excluded. The sample was divided into two subgroups based on age; of
the sample, 38.2% were 18-44 years of age and 61.8% were 45 years or older.
Demographic information was also collected, and the sample included 42.4% males,
57.6% females, 30.9% African American, 65% Caucasian, and 3.9% other race. The
primary care provider type was obtained during data collection and Nurse Practitioners
made up 72.8% while Medical Doctors made up 27.2%. Payor source was also noted,
and 60.8% of the population had commercial insurance, 29.7% had Medicare/Medicaid,
4.8% were private pay, and 3.7% had no payor source. A diagnosis of overweight,
obesity, or BMI ≥ 25 was included in the worksheet, and 74.3% of patients in the study
had at least one of these diagnoses in their chart during the last three years. A history of
CVD (angina, MI, or coronary stents) or a diagnosis of Essential Hypertension were
listed as risk factors for prediabetes and were included in the worksheet. For the
population only 13.8% of patients had one of these risk factors documented in the EMR.
Testing of at-risk patients was assessed by whether or not an A1C was completed. In this
study, 37.5% of patients 18-44 years of age had an A1C completed and 47.76% of
patients 45 years and older had an A1C completed. Of the patients tested with A1C for
prediabetes, 19.1% of the population met diagnostic criteria for prediabetes. For patients
who met criteria for prediabetes diagnosis, interventions were assessed and 85.5% of
prediabetic patients had an intervention recorded in the EMR. Metformin was given to
53.5%, recommended lifestyle changes were provided to 22.5%, and both Metformin and
lifestyle modifications were used for 23.9%.
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Of the 434 patients included in the sample, 342 (74.65%) from both subsets met
criteria for testing. Providers tested 149 (34.33%) of patients from both subsets meeting
criteria. No statistically significant difference in testing practice was found between
nurse practitioners and medical doctors (Nurse Practitioners vs. Medical Doctors), Χ2(2,
N=324) = 1.6, p=0.449. For the 149 patients who were tested, 83 (55%) were identified
as prediabetic. The subsample of patients aged 18 to 44 included 166 patients, and 56
(33.76%) of these patients met testing criteria. Primary care providers performed A1C
testing on 21 (37.5%) of this subset. No statistically significant difference in testing
practice was found between nurse practitioners and medical doctors, Χ2(2, N=56) = 1.38,
p=0.499. One hundred and three (62%) of patients in the 18 to 44 subgroup had a
diagnosis of overweight, obesity, or BMI ≥ 25 during the last three years, but only 56
(33.73%) had documented risk factors in the EMR. Due to the nature of this research
project, it was not feasible to include all of ADA’s risk factors for prediabetes in the
study; however, if all of the risk factors were included, it is likely there would have been
more patients meeting testing criteria. The subsample of patients age 45 and older
included 268 patients. Primary care providers performed A1C testing on 128 (47.76%)
of this subset. No statistically significant difference in testing practice was found
between nurse practitioners and medical doctors, Χ2(2, N=268) = 1.96, p=0.498. There
were 83 patients identified as prediabetic and interventions were recorded in 71 (85.5%)
of these records. Interventions for prediabetic patients included the following: metformin
53.5%, lifestyle modifications 22.5%, and both metformin and lifestyle modifications
23.9%. No statistically significant difference in interventions utilized were noted
between provider types, Χ2(2, N=71) = 3.468, p=0.177.
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According to the review of literature, prediabetes affects nearly 86 million
Americans and 90% of these people are unaware of their condition. The literature also
reveals that screening of patients according to ADA/USPSTF’s guidelines is suboptimal
with rates of 46%-85% (Mehta et al., 2017). The current research study reveals that
primary care providers in Mississippi are testing asymptomatic, at-risk patients at a
substandard level. For both subgroups, primary care providers tested 34.33% (n = 149)
of patients who met criteria. The researchers concluded that primary care providers
appropriately tested 37.5% of patients aged 18-44 and 47.76% of patients 45 years of age
and older.
In a study conducted by Tseng et al., only 6% of providers correctly identified all
of the risk factors for prediabetes. Consequently, a possible explanation for the lack of
testing could be that primary care providers are unaware of all the risk factors for
prediabetes. For the current research study, the researchers only studied the use of A1C
for diagnosis of prediabetes, however, the ADA includes fasting plasma glucose and
random plasma glucose as diagnostics. Mainous et al. surveyed physicians regarding
prediabetes and found that 52.1% of physicians used blood glucose concentrations for
their primary mode of testing. Subsequently, primary care providers in Mississippi may
also use other diagnostics not captured by the current study and may actually be
screening according to ADA’s guidelines. Mainous et al. also found that the primary
method of identifying someone at risk of developing diabetes was assessing BMI, testing
blood glucose concentrations, asking about family history, and other (p = 0.11).
For the current research project, 55% (n = 83) of patients who were tested met
diagnostic criteria for prediabetes. Whitley, Hanson, and Parton (2017) found that 53%
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of patients who were screened according to guidelines met diagnostic criteria for
prediabetes which is consistent with the findings of the current study. For patients who
were diagnosed with prediabetes, the primary care providers in this study ordered
interventions 85.5% of the time (n = 83). This number is consistent with findings in the
literature review (Mehta et al., 2017; Tseng et al., 2017). The interventions for
prediabetic patients included in this study were Metformin (53.5%), lifestyle
modifications (22.5%), and both Metformin and lifestyle modifications (23.9%). For the
purpose of this study, lifestyle modification is defined as any documentation of diet,
exercise, and/or weight loss counseling in the electronic medical record. Stentz et al.
2017 in a randomized, controlled trial of high protein versus high carbohydrate diets
found that 6 months into the study, the high protein diet group had a 100% remission of
prediabetes, compared to the high carbohydrate diet group with only a 33% remission.
The results of the study by Stentz et al. highlight the critical importance of diet education
for patients who are prediabetic.
Summary of findings
The researchers concluded that primary care providers in Mississippi tested
34.33% (n = 149) of the patients who met the guidelines for testing. This number may be
skewed, however, since the study did not include all of ADA’s risk factors for
prediabetes nor did it include plasma glucose values in the data collection. Primary care
providers tested 37.5% of the 18-44 age group and 47.76% of the ≥45 age group. 62% (n
= 103) of the 18-44 age group had a diagnosis of overweight, obesity, or BMI ≥ 25
during the last three years, but only 33.73% (n = 56) had documented risk factors that
were included in the current study. 55% (n = 83) of patients who were tested for
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prediabetes were indeed diagnosed with prediabetes. Primary care providers initiated
interventions in 85.5% of patients identified as prediabetic. No statistically significant
difference in testing practice or interventions was found between nurse practitioners and
medical doctors.
Limitations
The limitations of this study which were identified prior to data collection were
that only a small geographical area was studied, along with a small sample size being
collected. The study occurred within only five primary care clinics in Mississippi. The
researchers had a projected sample size of 500 patients (100 from each clinic) and of
those only 434 met requirements. A setting and sample this small did not provide
adequate generalization of the state of Mississippi or the United States as a whole. The
first target population of patients who were 18 years and older who were considered
obese or overweight based on diagnosis code or BMI, who also presented with one or
more risk factors for CVD or a diagnosis of Essential Hypertension provided another
limitation of a loose definition of CVD that was included in this study. The definition
that was supplied by the researchers was “patients with any history recorded in the
medical record of coronary stents, myocardial infarction, or angina.” This neglected
patients with peripheral vascular disease, atherosclerosis, cardiomyopathy, and others not
listed. This study also neglected patients who had exhibited signs and symptoms of a
form of CVD that had not been formally diagnosed.
Limitations were also identified during data collection. Utilizing only
retrospective chart reviews denied the quality aspect of the study. The treatment options
of prescription of Metformin, lifestyle modification, and/or both were adequate in
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treatment avenues, but neglected the quality of education provided in regard to lifestyle
modification. This did not account for the type of education provided such as exercise,
diet, a personalized plan, or all of the above. Another limitation was the formats of the
patients’ charts that were utilized and reviewed for data collection. Some charts provided
ease of access, as well as a detailed list of medical history, while some charts failed to
include BMI calculations and were difficult to navigate to determine the medical history
of patients. This could have increased the likelihood of human error of the researchers’
determination of who is included due to BMI or comorbidities, which could have caused
them to overlook important data.
Implications
An estimated 30.3 million American adults have diabetes in the United States and
of those 7.2 million are undiagnosed (CDC, 2015). In Mississippi, over 308,000 adults
are diabetic, which means the state accounts for the highest rate of diabetes in the country
(CDC, 2015). The CDC reports that 84.1 million adults in the United States are
prediabetic (CDC, 2017). Prediabetes increases the patient’s risk for developing diabetes,
cardiovascular disease, peripheral neuropathy, retinopathy, nephropathy, stroke,
infections, and many other potential life-threatening and life-altering conditions (ADA,
2019). With these high rates of prediabetes and under 12% of the population being aware
of their condition, many people progress to developing diabetes and develop target organ
damage of some sort without ever having knowledge of the detrimental effects (CDC,
2017). The ADA recommends lifestyle modification in the form of diet, exercise, and
weight loss along with early Metformin use for the prediabetic patient to prevent
complications (ADA, 2019). To provide education on these lifestyle modifications, the
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providers must be educated themselves on the signs and symptoms of prediabetes and
stay up to date on current screening guidelines.
This study was intended to provide education to primary care providers and
illuminate a gap in knowledge regarding testing practices. With the results of this
research study, the provider can adapt and transform their practice to adhere to testing
guidelines and reduce the detrimental effects of this condition. Providers have a fiduciary
responsibility to their patients to be aware of these problems and to act on their behalf to
test, diagnose, and treat patients according to current guidelines. Research has proven
that regular screening according to CDC guidelines, as well as early treatment of
prediabetic patients, can greatly reduce the chances of developing target organ damage
and progression to diabetes (CDC, 2017).
Recommendations
Recommendations for this study primarily include correction of the limitations.
For future research, it would improve generalization of the U.S. population with an
increased sample size, as well as increasing the geographical area studied. It would
provide a more in-depth representation of the quality of the education provided, plus how
the patients feel about their diagnosis could be identified. It is also pertinent to determine
the patient’s ability to adhere to the lifestyle modifications and medication regimen
provided. If the researchers in future studies were able to interview patients in person
versus this study only including retrospective chart reviews these limitations could be
rectified. Recommendations for future study would also include a qualitative review of
the providers and how they feel about their ability to recognize and diagnose prediabetes.
It is important to determine if they feel that it is a condition that can be reversed with
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early lifestyle modification, Metformin use, or both or not. If they feel that they cannot
stop progression to diabetes they may be more likely to treat only when the patient is
found to have diabetes.
Summary
This study was a retrospective chart review study that showed the quantity of the
patients who were tested and where trends of fallout occurred. The study failed to
determine the qualitative aspect of the reason the patients were not screened or treated
according to guidelines. Studies have been conducted to prove that early detection
through proactive testing practices, as well as early intervention, can decrease the
prevalence of this condition and reduce the amounts of patients who progress to diabetes.
There are limitations to this study that can be corrected and improved upon for
further testing, but this study provides a substantial foundation of realization that there is
a problem within the practice of testing and early treatment education and prescriptive
intervention. Further research will aid in determining the reason as to why the proactive
testing and treatment practices are not being adhered to in some areas or by some
providers.
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APPENDIX A
Data Collection Worksheet
1. Age:
18-44 (1)
45+ (2)
2. Gender:
Male (1)
Female (2)
3. Race:
African American (1)
Caucasian (2)
Other (3)
4. Provider type:
Nurse Practitioner (1)
Medical Doctor (2)
Doctor of Osteopathy (2)
Physician Assistance (4)
5. Payor Source:
Medicare/Medicaid (1)
Commercial (2)
Private Pay (3)
None (4)
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6. Within the last three years, has patient had either a diagnosis of ICD-10 E66.3
Overweight, ICD-10 E66.9 Obesity, or a BMI of 25 or greater?
Yes (1)
No (2)
7. Is patient ≥18 years old with presence of one or more risk factor for CVD
(angina, MI, or coronary stents) or a diagnosis of ICD-10 I10 Essential
Hypertension?
Yes (1), if yes skip to #9
No (2), if no proceed to #8
8. Is patient ≥45 years old?
Yes (1), if yes proceed to #9
No (2), if no exclude from data collection
9. Was an A1C test completed?
Yes (1)
No (2)
10. Did A1C test results fall between (A1C 5.7-6.4%) prediabetes?
Yes (1)
No (2)
11. If prediabetes was indicated, what interventions were utilized/implemented by
PCP?
Lifestyle Modification (1)
Metformin (2)

APPENDIX B
IRB Approval of Mississippi University for Women
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APPENDIX C
Consent to Conduct Study
To Whom It May Concern:
We are graduate students enrolled in the Family Nurse Practitioner program at
Mississippi University for Women. As a program requirement, we are conducting a
research project entitled: Assessment of Prediabetes Testing Practices of Primary
Care Providers in Mississippi. The goal of this research project is to determine if
primary care providers in Mississippi are testing asymptomatic patients, who are at
risk of developing diabetes, according to the American Diabetes Associations
recommendations. We will collect data by retrospective chart reviews obtaining the
following information: patient ≥18 years old; demographic information; provider
type; payor source; diagnosis of overweight (ICD-10 code E66.3), diagnosis of
obesity (ICD-10 code E66.9), or BMI ≥25; diagnosis of cardiovascular disease or
hypertension (ICD-10 code I10); hemoglobin A1C result; and prediabetes diagnosis
intervention. We are requesting permission to review medical records within your
practice that meet these criteria. We are aware that we will need to maintain
confidentiality throughout the entire process.
We agree to undergo or consent to any HIPAA requirements set forth by your practice
regarding patient privacy and confidentiality. All data collected during the chart review
will be recorded on a Data Collection Worksheet and stored under lock and key with
access only to the researchers. The data collected will not include any personal or
identifiable information for the patient or the clinic. The data will be kept confidential
and destroyed by incineration at the conclusion of the study, per HIPPA guidelines.
We understand that your participation in this study is strictly voluntary and you
may withdraw your consent and participation at any time up until data collection is
complete. Once the study is complete, the results will be made available to you and
may be beneficial as use as a quality assurance measure. If you have any questions
concerning this study, please contact the following committee members: Dr.
Sueanne Davidson, committee chair (Office: 662-329-7323 or Cell: 205-399-1433),
Marlana McFarland (662-315-0427), Blake McCaulley (662-415-7826), Erica
Mosley (601-616-2377), Yvette Munn (601-490-0619), or Lindsay Wynne (662710-2255).
Sincerely,
Blake McCaulley, Marlana McFarland, Erica Mosley, Yvette Munn, and Lindsay
Wynne
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I have read the above letter of consent and agree to the utilization of this clinic for
the abovementioned research project. It is my understanding that HIPPA
regulations will be strictly followed and that confidentiality will be maintained for
each chart reviewed. I also understand that the results of the study will be made
available to at the conclusion of the study.
________________________________________________________________
Signature, Name, Title, Date

